The Oncology Institute, Inc. TOI EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on the most recent quarter.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s EV / sales?
- The Oncology Institute, Inc. (TOI) reported EV / sales of 0.7× in Q1 2026.
- How has The Oncology Institute, Inc.'s EV / sales changed year-over-year?
- The Oncology Institute, Inc.'s EV / sales increased by 71.6% year-over-year, from 0.4× to 0.7×.
- What is the long-term trend for The Oncology Institute, Inc.'s EV / sales?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s EV / sales has grown at a -26.4% compound annual growth rate (CAGR), from 3.9× to 0.8×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.